Company Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine.
The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits.
It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution.
The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform.
Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.
| Country | United States |
| IPO Date | May 27, 2021 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 255 |
| CEO | Andrew Spaventa |
Contact Details
Address: 10931 North Torrey Pines Road La Jolla, California United States | |
| Website | https://singulargenomics.com |
Stock Details
| Ticker Symbol | OMIC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001850906 |
| CUSIP Number | 82933R100 |
| ISIN Number | US82933R1005 |
| Employer ID | 81-2948451 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Andrew Spaventa | Founder, Chief Executive Officer, President & Chairperson of the Board |
| Dalen Meeter | Chief Financial Officer |
| Dr. Jyotsna Ghai Ph.D. | Chief Operating Officer |
| Dr. David L. Barker Ph.D. | Founder, Member of Scientific Advisory Board & Independent Director |
| Dr. Eli N. Glezer Ph.D. | Founder, Chief Scientific Officer & Chair of Scientific Advisory Board |
| Eric Stier | Senior Vice President, General Counsel & Secretary |
| Jeff Bullard | Head of Sales |
| Jorge Velarde Jr., MBA | Chief Business Officer |
| Vincent Brancaccio | Head of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 06, 2025 | 4 | Filing |
| Dec 31, 2024 | PREM14A | Filing |
| Dec 26, 2024 | SCHEDULE 13D/A | [Amend] Filing |
| Dec 23, 2024 | DEFA14A | Filing |
| Dec 23, 2024 | 8-K | Current Report |
| Dec 17, 2024 | 4 | Filing |
| Dec 17, 2024 | 4 | Filing |
| Dec 17, 2024 | 4 | Filing |
| Nov 22, 2024 | SC 13D/A | [Amend] Filing |
| Nov 13, 2024 | 4 | Filing |